lobbying_activities: 1116310
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1116310 | b8f1f628-d97f-4ee9-8743-a7d251cedc2b | 2T | POLICY DIRECTIONS INC. | 31747 | ADVANCED LIFE SCIENCES | 2011 | second_quarter | MED | FDA regulatory pathway for new antibiotic medicines. | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2011-07-18T10:06:59.290000-04:00 |